| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 21, 2002
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its second quarter fiscal 2002 ended December 29, 2001, on Wednesday, January 23, 2002 at approximately...
-
Dec 4, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market over-the-counter (OTC) tioconazole...
-
Oct 23, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the first quarter of fiscal 2002 ended September 29, 2001. Net sales for fiscal 2002's first quarter increased 13 percent to $217.1...
-
Oct 19, 2001
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fiscal 2002 first quarter ended September 29, 2001, on Tuesday, October 23, 2001 at approximately 8:30...
-
Oct 11, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share...
-
Aug 15, 2001
Perrigo Company today announced that, in cooperation with the U.S. Food and Drug Administration (FDA), it is conducting a recall of 7,788 four-ounce bottles of cherry-flavored pain reliever...
-
Aug 15, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the fourth quarter and fiscal year ended June 30, 2001. For the fourth quarter, net sales were $180.9 million, an increase of 19 percent...
-
Aug 2, 2001
Perrigo Company (NASDAQ: PRGO) today announced preliminary results for the Company's fiscal 2001 fourth quarter, which ended June 30, 2001. For the fourth quarter, Perrigo expects to report net...
-
Jun 29, 2001
The Perrigo Company (NASDAQ: PRGO) today announced it has acquired Wrafton Laboratories Ltd., a store brand supplier to grocery and pharmacy retailers in the U.K. and a contract manufacturer of...
-
Jun 7, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it has received approval to market and distribute Ibuprofen and Pseudoephedrine Hydrochloride Tablets USP, 200 mg and 30 mg respectively,...